Patents Examined by Addison D Ault
  • Patent number: 8466271
    Abstract: The invention concerns novel regulatory elements as well as related vectors and cells. Furthermore, it relates to methods of improving expression of polypeptides from nucleic acids such as cloned genes and to the production of various polypeptides in host cells using said novel regulatory elements. Additionally, the invention relates to uses of said novel regulatory elements as insulators, in gene therapy or for improving host cell lines.
    Type: Grant
    Filed: July 22, 2009
    Date of Patent: June 18, 2013
    Assignee: Boehringer Ingelheim Pharma GmbH & Co, KG
    Inventor: Barbara Enenkel
  • Patent number: 8455216
    Abstract: The present invention provides compositions and methods for reducing H2S levels in fermented beverages.
    Type: Grant
    Filed: July 7, 2012
    Date of Patent: June 4, 2013
    Assignee: The Regents of the University of California
    Inventors: Linda F. Bisson, Angela Linderholm, Kevin L. Dietzel
  • Patent number: 8426569
    Abstract: The present invention relates to unnatural base pairs of Ds (a 7-(2 thienyl)-3H-imidazo[4,5-b]pyridine-3-yl group) and a Pa derivative (a 2-nitro-1H-pyrrole-1-yl group bearing a substituent having a ?-electron system attached at position 4) that can be replicated with high selectivity/high efficiency, and methods for replicating nucleic acids containing the unnatural base pairs. The present invention also relates to methods for incorporating an unnatural base bearing a functional substituent attached thereto into DNA by a nucleic acid replication reaction. The present invention also relates to methods for replicating and selectively collecting a nucleic acid containing an unnatural base pair from a nucleic acid pool. The present invention also relates to methods for determining a sequence of natural bases in the proximity of an unnatural base in DNA for achieving highly efficient and highly selective replication of a nucleic acid containing the unnatural base.
    Type: Grant
    Filed: March 31, 2009
    Date of Patent: April 23, 2013
    Assignees: Riken, Tagcyx Biotechnologies
    Inventors: Ichiro Hirao, Michiko Hirao, Shigeyuki Yokoyama
  • Patent number: 8420782
    Abstract: The present invention refers to methods for selectively recognizing a base pair in a DNA sequence by a polypeptide, to modified polypeptides which specifically recognize one or more base pairs in a DNA sequence and, to DNA which is modified so that it can be specifically recognized by a polypeptide and to uses of the polypeptide and DNA in specific DNA targeting as well as to methods of modulating expression of target genes in a cell.
    Type: Grant
    Filed: January 31, 2012
    Date of Patent: April 16, 2013
    Inventors: Ulla Bonas, Jens Boch, Sebastian Schornack, Thomas Lahaye
  • Patent number: 8404485
    Abstract: A coated microcarrier for cell culture includes a microcarrier base and a polymeric coating grafted to the base via a polymerization initiator. A method for forming the coated microcarrier includes (i) conjugating a polymerization initiator to the microcarrier base to form an initiator-conjugated microcarrier base; (ii) contacting the initiator-conjugated microcarrier base with monomers; and (iii) activating the initiator to initiate polymerization and graft the polymer to the base.
    Type: Grant
    Filed: July 25, 2012
    Date of Patent: March 26, 2013
    Assignee: Corning Incorporated
    Inventors: Kevin Robert McCarthy, Simon Kelly Shannon, Florence Verrier
  • Patent number: 8372601
    Abstract: The disclosure of the present application provides polypeptide sequences and nucleotide sequences coding for the polypeptide sequences of proteins used in the production of APPA-containing peptides. In at least one embodiment of the present disclosure, an isolated nucleic acid is disclosed which comprises a nucleotide sequence encoding a polypeptide having a sequence identity of 60 percent or greater to an amino acid sequence selected from the group consisting of SEQ ID NOS: 2-13, and 15-23.
    Type: Grant
    Filed: January 21, 2011
    Date of Patent: February 12, 2013
    Assignee: University of Illinois at Urbana-Champaign
    Inventors: William W. Metcalf, Wilfred A. van der Donk, Junkal Zhang, Benjamin T. Circello, Svetlana A. Borisova
  • Patent number: 8361744
    Abstract: The present invention relates generally to the fields of molecular biology and protein technology. More specifically, the invention concerns signal sequences for the secretion of heterologous polypeptide from bacteria. The invention also concerns recombinant polypeptides and uses thereof.
    Type: Grant
    Filed: November 5, 2010
    Date of Patent: January 29, 2013
    Assignee: Genentech, Inc.
    Inventors: Matthew Marrichi, Dorothea E. Reilly
  • Patent number: 8357509
    Abstract: Disclosed herein are recombinant tobacco osmotin polypeptides and methods for expressing tobacco osmotin polypeptides in microbial host cells. The recombinant tobacco osmotin polypeptides produced by the methods disclosed herein may be utilized as biocides or as therapeutic agents in medicaments.
    Type: Grant
    Filed: December 17, 2010
    Date of Patent: January 22, 2013
    Assignee: Auburn University
    Inventors: Tung-Shi Huang, Ywh-Min Tzou, Narendra Slngh, Bryan A. Chin
  • Patent number: 8338096
    Abstract: The present invention relates to the method of determining the risk of acute kidney injury comprising determining the amount of a marker selected from VCAN, NRP1, CCL2, CCL19, COL3A1, GZMM or any combination thereof in a sample.
    Type: Grant
    Filed: April 15, 2009
    Date of Patent: December 25, 2012
    Inventors: Rainer Oberbauer, Alexander Kainz, Bernd Mayer, Paul Perco
  • Patent number: 8329464
    Abstract: The present disclosure uses different kinds of surface treatment processes on titanium-made dental implants. The growth and attachment conditions of bone cells (MC3T3-E), fibroblasts (NIH 3T3) and epidermal cells (XB-2) on the metal surface of titanium slices with different surface treatments are observed. Tetra-calcium phosphate is used to perform secondary sand-blasting process to clean up the metal surface and provide calcium ions for osteoblastoma physiology. Thus, by adjusting the cells adhesive and proliferative abilities, the success rate of the clinical applications in dental implant is improved.
    Type: Grant
    Filed: September 1, 2010
    Date of Patent: December 11, 2012
    Assignee: Kaohsiung Medical University
    Inventors: Wen-Cheng Chen, Chun-Cheng Hung, Chia-Ling Ko
  • Patent number: 8329402
    Abstract: The present invention relates to a new combination of marker genes for characterizing a Lactobacillus sakei strain. In particular, the present invention concerns the use of a pattern of presence or absence of marker genes in the genome of the strain to be characterized for classifying and identifying said strain.
    Type: Grant
    Filed: February 20, 2009
    Date of Patent: December 11, 2012
    Assignee: Institut National de la Recherche Agronomique
    Inventors: Stéphane Chaillou, Monique Zagorec, Marie-Christine Champomier-Verges
  • Patent number: 8318454
    Abstract: The object is to provide a transformant which can produce a heterologous protein having a structurally controlled O-linked sugar chain having an O-Man-Gal disaccharide structure, a method for producing the transformant by using Schizosaccharomyces pombe as the host, and provide a host for producing the transformant and a method for producing an O-glycosylated heterologous protein. An Schizosaccharomyces pombe host having no omh1 gene or an inactivated omh1 gene in its chromosomes for producing an O-glycosylated heterologous protein having an O-linked sugar chain having an O-Man-Gal disaccharide structure by expression of the heterologous protein by a genetic engineering technique and subsequent glycosylation of the expressed heterologous protein. A transformant from the host, a method for producing the transformant and a method for producing an O-glycosylated heterologous protein by using the transformant.
    Type: Grant
    Filed: March 31, 2011
    Date of Patent: November 27, 2012
    Assignee: Asahi Glass Company, Limited
    Inventors: Kaoru Takegawa, Yuko Hama, Chihiro Hama, legal representative, Hideki Tohda
  • Patent number: 8278049
    Abstract: The present invention provides compositions and methods for selectively enriching genomic CpG island (CGI)- and other epigenetically informative CG-rich polynucleotide targets. The method involves co-incubation of denatured or partially denatured polynucleotide fragments containing the CGI- or CG-targeted region(s) of interest with an oligonucleotide capture pool collectively designed to selectively target CGIs. The oligonucleotide capture pool includes a plurality of different oligonucleotides, each oligonucleotide coupled to a capture tag, whereby the oligonucleotide includes a CpG target sequence restricted to 4 to 10 bases. Upon binding, capture oligonucleotides bound to the target fragments are enriched by separating the bound fragments from the unbound fragments. The enriched fragments may be subjected to further analyses, including bisulfite sequencing to generate a methylation profile at the single nucleotide level.
    Type: Grant
    Filed: April 26, 2010
    Date of Patent: October 2, 2012
    Assignee: Ann & Robert H. Lurie Children's Hospital of Chicago
    Inventor: Hehuang Xie
  • Patent number: 8257828
    Abstract: A coated microcarrier for cell culture includes a microcarrier base and a polymeric coating grafted to the base via a polymerization initiator. A method for forming the coated microcarrier includes (i) conjugating a polymerization initiator to the microcarrier base to form an initiator-conjugated microcarrier base; (ii) contacting the initiator-conjugated microcarrier base with monomers; and (iii) activating the initiator to initiate polymerization and graft the polymer to the base.
    Type: Grant
    Filed: July 27, 2010
    Date of Patent: September 4, 2012
    Assignee: Corning Incorporated
    Inventors: Kevin Robert McCarthy, Simon Kelly Shannon, Florence Verrier
  • Patent number: 8252583
    Abstract: A method for inducing differentiation of ES cells into cardiomyocytes, which comprises contacting the ES cells with an agonist for G-CSF receptor.
    Type: Grant
    Filed: June 6, 2008
    Date of Patent: August 28, 2012
    Assignee: Keiichi Fukuda
    Inventors: Keiichi Fukuda, Shinsuke Yuasa, Kenichiro Shimoji
  • Patent number: 8236527
    Abstract: The present invention relates to novel expression cassettes and vectors for efficiently producing authentic recombinant human proteins from stable cultures of novel human cell lines, the authentic recombinant proteins produced therefrom, and antibodies raised against those authentic recombinant proteins.
    Type: Grant
    Filed: March 12, 2009
    Date of Patent: August 7, 2012
    Assignee: Humanzyme Limited
    Inventors: Ridong Chen, Soon Seog Jeong, Hui Feng
  • Patent number: 8216803
    Abstract: The present invention provides compositions and methods for reducing H2S levels in fermented beverages.
    Type: Grant
    Filed: March 13, 2008
    Date of Patent: July 10, 2012
    Assignee: The Regents of the University of California
    Inventors: Linda F. Bisson, Angela Linderholm, Kevin L. Dietzel
  • Patent number: 8039256
    Abstract: To efficiently select and proliferate the mesenchymal stem cells without necessity of an exclusive separating device and a complicated separating operation, mesenchymal stem cells are cultured by seeding at least one of a bone marrow solution, an umbilical cord blood, a peripheral blood, a synovial membrane and an amniotic membrane in a liquid culture medium which is filled in a vessel, includes water as its main components and having a specific gravity between 1.06 and 1.10 at 37° C., and making a culture at a temperature 37±2° C. on a ceiling side surface of the vessel, preferably the specific gravity being regulated by use of at least one selected from silica fine powder coated by polyvinyl pyrrolidone, a water soluble copolymer of sucrose and epichlorohydrin, and a water soluble compound including a triiodo aromatic ring.
    Type: Grant
    Filed: September 28, 2010
    Date of Patent: October 18, 2011
    Assignees: GC Corporation, Two Cells Co., Ltd.
    Inventors: Yuhiro Sakai, Katsuyuki Yamanaka, Mika Takeda, Tomohisa Okura, Koichiro Tsuji